feed,title,long_url,short_url
Benzinga,Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off,https://benzinga.com/m-a/24/07/39916116/insulin-device-maker-embecta-weighs-sale-after-70-share-decline-following-becton-dickinson-spin-off,https://da.gd/i3eZ67
Benzinga,"'Dogecoin Killer' Shiba Inu Burn Rate Spikes 1,947% As Marketing Lead Predicts 'Altcoin Season'",https://benzinga.com/markets/cryptocurrency/24/07/39916096/dogecoin-killer-shiba-inu-burn-rate-spikes-1-947-as-marketing-lead-predicts-altcoin-season,https://da.gd/bRnF0
Benzinga,TSMC's Latest Results Show It Is More Than A Beneficiary Of The AI Hype As It Is One Of One Its Creators,https://benzinga.com/news/24/07/39916079/tsmcs-latest-results-show-it-is-more-than-a-beneficiary-of-the-ai-hype-as-it-is-one-of-one-its-creat,https://da.gd/v7FYc
Benzinga,Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants,https://benzinga.com/general/biotech/24/07/39916077/merck-competes-with-sanofiastrazeneca-as-its-rsv-treatment-drug-meets-primary-goal-in-late-stage-,https://da.gd/ttdyg
